Find Resources
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Op-ed
This op-ed discusses the minimal progress that has been made towards understanding the causes and treatment of long COVID. The main crux of the author’s argument is that long COVID is essentially the same condition as post-infectious syndrome or myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). Thus, long COVID is actually not a new condition, but rather something triggered by acute COVID in the same way that many other illnesses can trigger ME/CFS in individuals. ME/CFS itself is not well-understood, but the years of research and patient experiences with the condition could be applied to the body of long COVID research for the advancement of both causes.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Other
The article discusses the challenges and frustrations surrounding Long COVID research in the United States. Despite substantial investments and numerous research efforts, progress in understanding and treating Long COVID has been slow and disappointing. Experts and patient advocates have criticized the research community for its focus on disease development rather than direct patient care, duplication of studies, and a lack of clinical trials. The authors propose a new hypothesis that Long COVID may be a form of post-infectious syndrome or chronic fatigue syndrome, suggesting that traditional biomedical research approaches may not yield meaningful results. Instead, they advocate for a shift towards health services research and measures that directly impact patients’ welfare, including prevention, improved prognosis, access to empathetic care, and quality of life issues. They emphasize the need for collaboration between researchers, patients, and advocacy groups to reset the research agenda effectively.